CLINICAL STUDY
Calcium antagonists reduce cardiovascular complications after cardiac surgery
A meta-analysis
Duminda N. Wijeysundera, MD*,
W. Scott Beattie, MD, PhD ,*,
Vivek Rao, MD, PhD and
Jacek Karski, MD
* Department of Anesthesia, University of Toronto, Toronto, Ontario, Canada
Department of Anesthesia, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada
Division of Cardiac Surgery, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada
Manuscript received July 23, 2002;
revised manuscript received November 13, 2002,
accepted November 27, 2002.
* Reprint requests and correspondence: Dr. W. Scott Beattie, Associate Professor, Department of Anaesthesia, University of Toronto, EN 3-453, Toronto General Hospital, University Health Network, 200 Elizabeth Street, Toronto, Ontario, M5G 2C4, Canada.
scott.beattie{at}uhn.on.ca
OBJECTIVES: We sought to determine the efficacy of calcium antagonists (CAs) in reducing death, myocardial infarction (MI), ischemia, and supraventricular tachyarrhythmia (SVT) after cardiac surgery.
BACKGROUND: Calcium antagonists may reduce complications after cardiac surgery—namely, death, MI, and renal failure. However, they are underused, possibly due to the results from previous observational studies.
METHODS: Both MEDLINE (1966 to December 2001) and EMBASE (1980 to December 2001) were searched, with supplementation by reference list searches. No language restrictions were applied. Included studies were randomized, controlled trials (RCTs) evaluating preoperative, intraoperative, or postoperative (first 48 h) CA use (intravenous or oral) during aortocoronary bypass or valve surgery. Studies were excluded if they exclusively recruited transplant recipients, individuals <18 years old, or patients with pre-existing SVT. Two reviewers independently evaluated study quality by using the Jadad score; a minimal score of 1/5 was required. Forty-one studies, encompassing 3,327 patients, were included. No studies assessed treatment exclusively with short-acting oral nifedipine. Treatment effects were calculated using the random-effects model. Heterogeneity was assessed using the Q test.
RESULTS: Calcium antagonists significantly reduced MI (odds ratio [OR] 0.58, 95% confidence interval [CI] 0.37 to 0.91; p = 0.02) and ischemia (OR 0.53, 95% CI 0.39 to 0.72; p < 0.001). Non-dihydropyridines significantly reduced SVT (OR 0.62, 95% CI 0.41 to 0.93; p = 0.02). Calcium antagonists were associated with trends toward decreased mortality during aortocoronary bypass (OR 0.66, 95% CI 0.26 to 1.70, p = 0.4).
CONCLUSIONS: Use of CAs during cardiac surgery significantly reduced rates of MI, ischemia, and SVT. Further study using large RCTs is justified.
|
Abbreviations and Acronyms
| | CA | = calcium antagonist | | CABG | = coronary artery bypass graft surgery | | MI | = myocardial infarction | | RCT | = randomized, controlled trial | | SVT | = supraventricular tachyarrhythmia |
|
This article has been cited by other articles:
|
|
|
|
 
A. Brunelli, A. Charloux, C. T. Bolliger, G. Rocco, J-P. Sculier, G. Varela, M. Licker, M. K. Ferguson, C. Faivre-Finn, R. M. Huber, et al.
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
Eur. Respir. J.,
July 1, 2009;
34(1):
17 - 41.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Kaireviciute, A. Aidietis, and G. Y.H. Lip
Atrial fibrillation following cardiac surgery: clinical features and preventative strategies
Eur. Heart J.,
February 2, 2009;
30(4):
410 - 425.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Echahidi, P. Pibarot, G. O'Hara, and P. Mathieu
Mechanisms, Prevention, and Treatment of Atrial Fibrillation After Cardiac Surgery
J. Am. Coll. Cardiol.,
February 26, 2008;
51(8):
793 - 801.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. L Baker and C M. White
Post-Cardiothoracic Surgery Atrial Fibrillation: A Review of Preventive Strategies
Ann. Pharmacother.,
April 1, 2007;
41(4):
587 - 598.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. C. Burgess, M. J. Kilborn, and A. C. Keech
Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis
Eur. Heart J.,
December 1, 2006;
27(23):
2846 - 2857.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Auerbach and L. Goldman
Assessing and Reducing the Cardiac Risk of Noncardiac Surgery
Circulation,
March 14, 2006;
113(10):
1361 - 1376.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. S. Myles and D. McIlroy
Fast-Track Cardiac Anesthesia: Choice of Anesthetic Agents and Techniques
Seminars in Cardiothoracic and Vascular Anesthesia,
March 1, 2005;
9(1):
5 - 16.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. N. Wijeysundera, W. S. Beattie, V. Rao, J. Ivanov, and K. Karkouti
Calcium antagonists are associated with reduced mortality after cardiac surgery: a propensity analysis
J. Thorac. Cardiovasc. Surg.,
March 1, 2004;
127(3):
755 - 762.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Butterworth and C. D. Furberg
Improving Cardiac Outcomes After Noncardiac Surgery
Anesth. Analg.,
September 1, 2003;
97(3):
613 - 615.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. N. Wijeysundera and W. S. Beattie
Calcium Channel Blockers for Reducing Cardiac Morbidity After Noncardiac Surgery: A Meta-Analysis
Anesth. Analg.,
September 1, 2003;
97(3):
634 - 641.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
